ArticleThe journal of venomous animals and toxins including tropical diseases2021
Scorpion species of medical importance in the Brazilian Amazon: a review to identify knowledge gaps.
Article in The journal of venomous animals and toxins including tropical diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 51 citations in OpenAlex.
- A Hydrolase-Rich Venom Beyond Neurotoxins: Integrative Functional Proteomic and Immunoreactivity Analyses Reveal Novel Peptides in the Amazonian ScorpionInternational journal of molecular sciences · 2026Article
- Scorpionism in the Amazon: Evidence, Challenges and Actions for Controlling a Neglected Disease.Revista da Sociedade Brasileira de Medicina Tropical · 2026Review
- Article
- Article
- A novel scorpine-like peptide from the amazonian scorpionFrontiers in pharmacology · 2025Article
- Scorpions are taking over: the silent and escalating public health crisis in Brazil.Frontiers in public health · 2025Article
- Scorpionism in Pará, Brazil: Clinical assessment of neuromuscular manifestations.Revista da Sociedade Brasileira de Medicina Tropical · 2025Observational
- Exploring the potential of Brazilian Amazonian scorpion venoms: A comprehensive review of research from 2001 to 2021.Toxicon: X · 2024Review
- Immunosuppressive therapies in scorpion envenomation: new perspectives for treatment.Frontiers in toxicology · 2024Review
- Identification of an Antimicrobial Peptide from the Venom of the Trinidad Thick-Tailed ScorpionAntibiotics (Basel, Switzerland) · 2023Article
- Scorpion envenomation in Brazil: Current scenario and perspectives for containing an increasing health problem.PLoS neglected tropical diseases · 2023Review
- Antifungal activity ofToxicon: X · 2022Article
- Recombinant expression and antigenicity of two peptide families of neurotoxins fromThe journal of venomous animals and toxins including tropical diseases · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Scorpionism is a relevant medical condition in Brazil. It is responsible for most accidents involving venomous animals in the country, which leads to severe symptoms that can evolve to death. In recent years, an increase of almost 50% in the incidence of scorpionism has been observed in the Northern Region, where the highest severity of envenoming has been notified since the beginning of the 21
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.